A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis
Status: | Completed |
---|---|
Conditions: | Arthritis, Arthritis, Neurology, Orthopedic |
Therapuetic Areas: | Neurology, Rheumatology, Orthopedics / Podiatry |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 11/30/2018 |
Start Date: | May 2, 2016 |
End Date: | October 17, 2018 |
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
The main purpose of this study is to evaluate the safety and efficacy of the study drug known
as ixekizumab in biological disease-modifying anti-rheumatic drugs (bDMARDs)-naive
participants with radiographic axial spondyloarthritis (rad-axSpA).
as ixekizumab in biological disease-modifying anti-rheumatic drugs (bDMARDs)-naive
participants with radiographic axial spondyloarthritis (rad-axSpA).
Inclusion Criteria:
- Are ambulatory.
- Diagnosis of radiographic axial spondyloarthritis (rad-xSpA) with sacroiliitis defined
radiographically according to the modified New York criteria.
- Participants have a history of back pain ≥3 months with age at onset <45 years.
- In the past had an inadequate response to at least 2 non-steroidal anti-inflammatory
drugs (for duration 4 weeks) or cannot tolerate NSAIDS.
- If taking NSAIDS be on a stable dose for at least 2 weeks prior to randomization.
- Have a history of prior therapy for axSpa for at least 12 weeks prior to screening.
Exclusion Criteria:
- Have total ankylosis of the spine.
- Have received any prior, or are currently receiving, treatment with biologics, tumor
necrosis factor inhibitors or other immunomodulatory agents.
- Have recently received a live vaccine within 12 weeks or have had a vaccination with
Bacillus Calmette-Guerin (BCG) within the past year.
- Have an ongoing or serious infection within the last 12 weeks or evidence of active
tuberculosis.
- Have a compromised immune system.
- Have any other serious and/or uncontrolled diseases.
- Have either a current diagnosis or a recent history of malignant disease.
- Have had major surgery within 8 weeks of baseline, or will require surgery during the
study.
- Are pregnant or breastfeeding.
We found this trial at
20
sites
Lincoln, Nebraska 68512
Principal Investigator: Melvin Churchill
Phone: 402-420-1212
Click here to add this to my saved trials
7000 Fannin St
Houston, Texas 77030
Houston, Texas 77030
(713) 500-4472
Principal Investigator: John Reveille
Phone: 713-500-6900
University of Texas Health Science Center at Houston The University of Texas Health Science Center...
Click here to add this to my saved trials
Click here to add this to my saved trials
Colorado Springs, Colorado 80920
Principal Investigator: Michael Sayers
Phone: 719-475-9616
Click here to add this to my saved trials
Click here to add this to my saved trials
Cumberland, Maryland 21502
Principal Investigator: Steven Klein
Phone: 301-724-4337
Click here to add this to my saved trials
Denver, Colorado 80230
Principal Investigator: Ryan Antolini
Phone: 303-394-2828
Click here to add this to my saved trials
Elizabethtown, Kentucky 42701
Principal Investigator: Daksha Mehta
Phone: 270-769-2535
Click here to add this to my saved trials
Hagerstown, Maryland 21740
Principal Investigator: Mary Howell
Phone: 301-791-6680
Click here to add this to my saved trials
19582 Beach Boulevard
Huntington Beach, California 92648
Huntington Beach, California 92648
Principal Investigator: Christine Thai
Phone: 949-385-0469
Click here to add this to my saved trials
Kalispell, Montana 59901
Principal Investigator: Roger Diegel
Phone: 406-755-1460
Click here to add this to my saved trials
Marietta, Georgia 30060
Principal Investigator: Roel Querubin
Phone: 770-590-8328
Click here to add this to my saved trials
North Charleston, South Carolina 29406
Principal Investigator: Clarence Legerton
Phone: 843-572-1818
Click here to add this to my saved trials
Palm Desert, California 92260
Principal Investigator: Maria Greenwald
Phone: 760-341-6800
Click here to add this to my saved trials
Phoenix, Arizona 85032
Principal Investigator: Eric Peters
Phone: 480-626-6653
Click here to add this to my saved trials
Raleigh, North Carolina 27617
Principal Investigator: Joseph Shanahan
Phone: 919-405-2040
Click here to add this to my saved trials
Saint Louis, Missouri 63141
Principal Investigator: Akgun Ince
Phone: 314-567-5100
Click here to add this to my saved trials
Sarasota, Florida 34239
Principal Investigator: Jeffrey Kaine
Phone: 941-485-8314
Click here to add this to my saved trials
Spokane, Washington 99204
Principal Investigator: Eric Mueller
Phone: 509-838-6500
Click here to add this to my saved trials
Trumbull, Connecticut 06611
Principal Investigator: Geoffrey Gladstein
Phone: 203-374-9816
Click here to add this to my saved trials